skip to main content
DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

This content will become publicly available on March 13, 2021

Title: Lycorine targets multiple myeloma stem cell‐like cells by inhibition of Wnt/β‐catenin pathway

Authors:
 [1];  [1];  [2];  [3];  [1];  [4];  [5];  [6];  [6];  [1];  [7];  [7];  [1]; ORCiD logo [1];  [8]; ORCiD logo [1]
  1. Molecular Biology Research Center &, Hunan Province Key Laboratory of Basic and Applied Hematology School of Life Sciences Central South University Changsha China
  2. Molecular Biology Research Center &, Hunan Province Key Laboratory of Basic and Applied Hematology School of Life Sciences Central South University Changsha China, Hematology Department Xiangya HospitalCentral South University Changsha China
  3. Department of Histology and Embryology of School of Basic Medical Sciences Central South University ChangshaChina
  4. Molecular Science and Biomedicine Laboratory State Key Laboratory for Chemo/Biosensing and Chemometrics College of Biology College of Chemistry and Chemical Engineering Hunan University ChangshaChina
  5. Molecular Biology Research Center &, Hunan Province Key Laboratory of Basic and Applied Hematology School of Life Sciences Central South University Changsha China, Molecular Science and Biomedicine Laboratory State Key Laboratory for Chemo/Biosensing and Chemometrics College of Biology College of Chemistry and Chemical Engineering Hunan University ChangshaChina
  6. Cancer Research Institute School of Basic Medical Science Central South University ChangshaChina
  7. Xiangya Medical School Central South University ChangshaChina
  8. Lymphoma &, Hematology Department the Affiliated Tumor Hospital of Xiangya Medical School of Central South University Changsha China
Publication Date:
Sponsoring Org.:
USDOE Office of Electricity Delivery and Energy Reliability (OE), Power Systems Engineering Research and Development (R&D) (OE-10)
OSTI Identifier:
1604502
Grant/Contract Number:  
[2018YFA0107800]
Resource Type:
Publisher's Accepted Manuscript
Journal Name:
British Journal of Haematology
Additional Journal Information:
[Journal Name: British Journal of Haematology]; Journal ID: ISSN 0007-1048
Publisher:
Wiley-Blackwell
Country of Publication:
United Kingdom
Language:
English

Citation Formats

Wang, Haiqin, Gong, Yanfei, Liang, Long, Xiao, Ling, Yi, Hui, Ye, Mao, Roy, Mridul, Xia, Jiliang, Zhou, Wen, Yang, Chaoying, Shen, Xiaokai, Zhang, Boxin, Li, Zhenzhen, Liu, Jing, Zhou, Hui, and Xiao, Xiaojuan. Lycorine targets multiple myeloma stem cell‐like cells by inhibition of Wnt/β‐catenin pathway. United Kingdom: N. p., 2020. Web. doi:10.1111/bjh.16477.
Wang, Haiqin, Gong, Yanfei, Liang, Long, Xiao, Ling, Yi, Hui, Ye, Mao, Roy, Mridul, Xia, Jiliang, Zhou, Wen, Yang, Chaoying, Shen, Xiaokai, Zhang, Boxin, Li, Zhenzhen, Liu, Jing, Zhou, Hui, & Xiao, Xiaojuan. Lycorine targets multiple myeloma stem cell‐like cells by inhibition of Wnt/β‐catenin pathway. United Kingdom. doi:10.1111/bjh.16477.
Wang, Haiqin, Gong, Yanfei, Liang, Long, Xiao, Ling, Yi, Hui, Ye, Mao, Roy, Mridul, Xia, Jiliang, Zhou, Wen, Yang, Chaoying, Shen, Xiaokai, Zhang, Boxin, Li, Zhenzhen, Liu, Jing, Zhou, Hui, and Xiao, Xiaojuan. Fri . "Lycorine targets multiple myeloma stem cell‐like cells by inhibition of Wnt/β‐catenin pathway". United Kingdom. doi:10.1111/bjh.16477.
@article{osti_1604502,
title = {Lycorine targets multiple myeloma stem cell‐like cells by inhibition of Wnt/β‐catenin pathway},
author = {Wang, Haiqin and Gong, Yanfei and Liang, Long and Xiao, Ling and Yi, Hui and Ye, Mao and Roy, Mridul and Xia, Jiliang and Zhou, Wen and Yang, Chaoying and Shen, Xiaokai and Zhang, Boxin and Li, Zhenzhen and Liu, Jing and Zhou, Hui and Xiao, Xiaojuan},
abstractNote = {},
doi = {10.1111/bjh.16477},
journal = {British Journal of Haematology},
number = ,
volume = ,
place = {United Kingdom},
year = {2020},
month = {3}
}

Journal Article:
Free Publicly Available Full Text
This content will become publicly available on March 13, 2021
Publisher's Version of Record

Save / Share:

Works referenced in this record:

Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update
journal, April 2015

  • Takebe, Naoko; Miele, Lucio; Harris, Pamela Jo
  • Nature Reviews Clinical Oncology, Vol. 12, Issue 8
  • DOI: 10.1038/nrclinonc.2015.61

Embryonic stem cells require Wnt proteins to prevent differentiation to epiblast stem cells
journal, August 2011

  • ten Berge, Derk; Kurek, Dorota; Blauwkamp, Tim
  • Nature Cell Biology, Vol. 13, Issue 9
  • DOI: 10.1038/ncb2314

Bruton Tyrosine Kinase Is a Therapeutic Target in Stem-like Cells from Multiple Myeloma
journal, January 2015


Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells
journal, May 2012


XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos
journal, August 1996


Stem cells, cancer, and cancer stem cells
journal, November 2001

  • Reya, Tannishtha; Morrison, Sean J.; Clarke, Michael F.
  • Nature, Vol. 414, Issue 6859
  • DOI: 10.1038/35102167

Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?
journal, September 2015

  • Franqui-Machin, Reinaldo; Wendlandt, Erik B.; Janz, Siegfried
  • Oncotarget, Vol. 6, Issue 38
  • DOI: 10.18632/oncotarget.5800

The myeloma stem cell concept, revisited: from phenomenology to operational terms
journal, November 2016


Future Directions of Next-Generation Novel Therapies, Combination Approaches, and the Development of Personalized Medicine in Myeloma
journal, May 2011

  • Mitsiades, Constantine S.; Davies, Faith E.; Laubach, Jacob P.
  • Journal of Clinical Oncology, Vol. 29, Issue 14
  • DOI: 10.1200/JCO.2010.34.0760

CXCL12 and CXCR7 are relevant targets to reverse cell adhesion-mediated drug resistance in multiple myeloma
journal, July 2017

  • Waldschmidt, Johannes M.; Simon, Anna; Wider, Dagmar
  • British Journal of Haematology, Vol. 179, Issue 1
  • DOI: 10.1111/bjh.14807

Lycorine Promotes Autophagy and Apoptosis via TCRP1/Akt/mTOR Axis Inactivation in Human Hepatocellular Carcinoma
journal, September 2017


Wnt/Wingless Signaling Requires BCL9/Legless-Mediated Recruitment of Pygopus to the Nuclear β-Catenin-TCF Complex
journal, April 2002


New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)
journal, November 2013

  • Ocio, E. M.; Richardson, P. G.; Rajkumar, S. V.
  • Leukemia, Vol. 28, Issue 3
  • DOI: 10.1038/leu.2013.350

Side population cells in human cancers
journal, September 2008


Bortezomib Augments Natural Killer Cell Targeting of Stem-Like Tumor Cells
journal, January 2019


A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
journal, November 2006

  • O’Brien, Catherine A.; Pollett, Aaron; Gallinger, Steven
  • Nature, Vol. 445, Issue 7123
  • DOI: 10.1038/nature05372

Targeting the β-catenin/TCF transcriptional complex in the treatment of multiple myeloma
journal, April 2007

  • Sukhdeo, Kumar; Mani, Mala; Zhang, Yunyu
  • Proceedings of the National Academy of Sciences, Vol. 104, Issue 18
  • DOI: 10.1073/pnas.0610299104

β-Catenin Inhibitor BC2059 Is Efficacious as Monotherapy or in Combination with Proteasome Inhibitor Bortezomib in Multiple Myeloma
journal, May 2017


TRAF6 function as a novel co-regulator of Wnt3a target genes in prostate cancer
journal, July 2019


Functional interaction of β-catenin with the transcription factor LEF-1
journal, August 1996

  • Behrens, Jürgen; von Kries, Jens P.; Kühl, Michael
  • Nature, Vol. 382, Issue 6592
  • DOI: 10.1038/382638a0

Targeted Disruption of the BCL9/ -Catenin Complex Inhibits Oncogenic Wnt Signaling
journal, August 2012


The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
journal, September 2001

  • Zhou, Sheng; Schuetz, John D.; Bunting, Kevin D.
  • Nature Medicine, Vol. 7, Issue 9
  • DOI: 10.1038/nm0901-1028

Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options
journal, February 2019


Tumorigenesis: Testing ground for cancer stem cells
journal, December 2011


Lycorine possesses notable anticancer potentials in on-small cell lung carcinoma cells via blocking Wnt/β-catenin signaling and epithelial-mesenchymal transition (EMT)
journal, January 2018

  • Sun, Yanfang; Wu, Pingping; Sun, Yang
  • Biochemical and Biophysical Research Communications, Vol. 495, Issue 1
  • DOI: 10.1016/j.bbrc.2017.11.032

Multiple Myeloma
journal, March 2011

  • Palumbo, Antonio; Anderson, Kenneth
  • New England Journal of Medicine, Vol. 364, Issue 11
  • DOI: 10.1056/NEJMra1011442

Lycorine Downregulates HMGB1 to Inhibit Autophagy and Enhances Bortezomib Activity in Multiple Myeloma
journal, January 2016

  • Roy, Mridul; Liang, Long; Xiao, Xiaojuan
  • Theranostics, Vol. 6, Issue 12
  • DOI: 10.7150/thno.15584

Targeting Hedgehog -- a Cancer Stem Cell Pathway
journal, June 2010


NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma
journal, September 2014


Effects of lycorine on HL-60 cells via arresting cell cycle and inducing apoptosis
journal, November 2004


BCL9 Promotes Tumor Progression by Conferring Enhanced Proliferative, Metastatic, and Angiogenic Properties to Cancer Cells
journal, September 2009


Stemness of B-cell Progenitors in Multiple Myeloma Bone Marrow
journal, September 2012


Critical Appraisal of the Side Population Assay in Stem Cell and Cancer Stem Cell Research
journal, February 2011


Lycorine inhibits melanoma cell migration and metastasis mainly through reducing intracellular levels of β‐catenin and matrix metallopeptidase 9
journal, November 2018

  • Zhang, Pan; Zhang, Mengli; Yu, Di
  • Journal of Cellular Physiology, Vol. 234, Issue 7
  • DOI: 10.1002/jcp.27732

Lycorine: A prospective natural lead for anticancer drug discovery
journal, November 2018


RARα2 expression confers myeloma stem cell features
journal, August 2013


Aldehyde Dehydrogenase as a Marker for Stem Cells
journal, December 2008


Pharmacologic screens reveal metformin that suppresses GRP78-dependent autophagy to enhance the anti-myeloma effect of bortezomib
journal, June 2015

  • Jagannathan, S.; Abdel-Malek, M. A. Y.; Malek, E.
  • Leukemia, Vol. 29, Issue 11
  • DOI: 10.1038/leu.2015.157

Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications
journal, April 2011


The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia
journal, June 2007